HighTower Advisors
GNOM icon

HighTower Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

HighTower Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,598
Closed -$121K – 3928
2025
Q2 		$121K Sell
3,598
-213
-6% -$6.74K ﹤0.01% 3431
2025
Q1 		$121K Buy
3,811
+546
+17% +$20.7K ﹤0.01% 3324
2024
Q4 		$127K Sell
3,265
-37
-1% -$1.55K ﹤0.01% 3322
2024
Q3 		$150K Sell
3,302
-28
-0.8% -$1.25K ﹤0.01% 3219
2024
Q2 		$139K Sell
3,330
-2,680
-45% -$112K ﹤0.01% 3130
2024
Q1 		$275K Sell
6,010
-1,271
-17% -$57.9K ﹤0.01% 2745
2023
Q4 		$337K Buy
7,281
+104
+1% +$4.24K ﹤0.01% 2614
2023
Q3 		$294K Sell
7,177
-1,755
-20% -$79.9K ﹤0.01% 2614
2023
Q2 		$434K Sell
8,932
-429
-5% -$21.5K ﹤0.01% 2296
2023
Q1 		$461K Sell
9,361
-6,790
-42% -$349K ﹤0.01% 2171
2022
Q4 		$818K Sell
16,151
-1,484
-8% -$76.5K ﹤0.01% 1793
2022
Q3 		$885K Buy
17,635
+3,525
+25% +$199K ﹤0.01% 1676
2022
Q2 		$690K Sell
14,110
-1,489
-10% -$75.5K ﹤0.01% 1863
2022
Q1 		$939K Buy
15,599
+535
+4% +$33.7K ﹤0.01% 1789
2021
Q4 		$1.2M Buy
15,064
+10,889
+261% +$915K ﹤0.01% 1674
2021
Q3 		$369K Buy
+4,175
New +$391K ﹤0.01% 2280

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

HighTower Advisors's GNOM Position: Q3 2025 in Review

HighTower Advisors sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 3,598 shares — an estimated $121K sold.

HighTower Advisors first reported a position in GNOM in Q3 2021 and held it in 16 quarters. The position peaked at $1.2M in Q4 2021. 41 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

  • HighTower Advisors reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • HighTower Advisors sold 3,598 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $121K.
  • HighTower Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and held it in 16 quarters.
  • HighTower Advisors's Global X Genomics & Biotechnology ETF position peaked at $1.2M in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.